Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alimta in Recurrent or Metastatic Nasopharyngeal Carcinoma
NCT00630149Phase 2Completed
- Sponsor
- Sun Yat-sen University
- Start
- Nov 2007
- Primary completion
- Nov 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pemetrexed in nasopharyngeal carcinoma (NPC), sponsored by Sun Yat-sen University. Started Nov 2007; status: completed.
02
Drugs
pemetrexed
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT00630149.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00630149.